Medtronic (NYSE:MDT) has had a lot of action in the courts today, with the Supreme Court sending a negligence lawsuit against the company up to the federal government for a 2nd opinion.
U.S. Supreme Court
Supreme Court declines to hear Medtronic appeal of Edwards Lifesciences win
Stent pioneer Saffran asks Supremes to hear appeal in $600M patent case against J&J’s Cordis
Stent pioneer Dr. Bruce Saffran asked the U.S. Supreme Court to hear an appeal of a lower court’s decision to overturn his $593 million win in a patent infringement lawsuit against Johnson & Johnson‘s (NYSE:JNJ) Cordis stent-making arm.
U.S. leans in Medtronic’s favor in Supreme Court case against Boston Scientific
Will the Supreme Court’s decision on “gene patents” stifle medical innovation?
The Supreme Court’s ruling did not hand a clear victory to either party.
Gene patents: Is the Myriad Genetics decision good news or bad news for medtech?
The Supreme Court’s unanimous decision to ban patents on human genes isn’t likely to be popular among companies that have staked their business around a gene-dependent patent, but it’s not entirely bad news for medical device maker and diagnostics companies.
FLASH: Supreme Court unanimously rules that human genes aren’t patentable
The Supreme Court today ruled unanimously that isolated human genes are not patentable, putting in jeopardy patents held by Myriad Genetics for genetic tests that identify genes tied to an increased risk of developing breast cancer and ovarian cancer.
The case hinged on the question of whether an human gene becomes a "human-made invention" once it’s targeted and isolated or whether it remains a "product of nature" and thus ineligible for patenting.
Supreme Court to hear Medtronic’s appeal of Boston Scientific’s CRM patent win
Medtronic asks Supreme Court to overturn $74M loss against Edwards Lifesciences
Supreme Court denies Retractable Technologies in patent war with BD
Supreme Court reopens Obamacare challenge | MassDevice.com On Call
MASSDEVICE ON CALL — The Supreme Court this week revisited the landmark healthcare reform decision that originally upheld the Affordable Care Act’s individual insurance mandate.
The Supreme Court decided to allow a lower court to proceed with a case against the law, getting the Obama administration’s nod to do so.